5299 篇
13868 篇
408774 篇
16079 篇
9269 篇
3869 篇
6464 篇
1238 篇
72401 篇
37108 篇
12060 篇
1619 篇
2821 篇
3387 篇
640 篇
1229 篇
1965 篇
4866 篇
3821 篇
5293 篇
全球宫颈癌诊断测试市场报告(2014-2018年)
Global Cervical Cancer Diagnostic Tests Market 2014-2018
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Paradigm
06.1 Epidemiology
06.2 Causes of Cervical Cancer
06.3 Diagnosis of Cervical Cancer
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Type of Test
08.1 Pap Smear Test
08.1.1 Conventional Pap
08.1.2 Liquid-based Cytology
08.2 HPV Testing
08.3 Colposcopy
08.4 Cervical Cancer Biopsy
08.4.1 LEEP
08.4.2 ECC
08.4.3 Cone Biopsy
08.5 Segmentation of Global Cervical Cancer
Diagnostic Tests Market by Type of Test
08.6 Global HPV Testing Market
08.6.1 Market Size and Forecast
08.7 Global Colposcopy Market
08.7.1 Market Size and Forecast
08.8 Global Pap Smear Test Market
08.8.1 Market Size and Forecast
08.9 Global Cervical Cancer Biopsy Market
08.9.1 Market Size and Forecast
09. Market Segmentation by Technology
09.1 ELISA
09.2 FISH
09.3 NASBA
09.4 PCR
09.5 Multichromatic Staining and Microscopy
09.6 Optical Imaging
10. Market Segmentation by Method
10.1 Molecular Method
10.2 Cytopathological Method
10.3 Physical Method
11. Geographical Segmentation
11.1 Geographical Segmentation of Global Cervical
Cancer Diagnostic Tests Market
11.2 Cervical Cancer Diagnostic Tests Market in
Americas
11.2.1 Market Size and Forecast
11.3 Cervical Cancer Diagnostic Tests Market in
EMEA Region
11.3.1 Market Size and Forecast
11.4 Cervical Cancer Diagnostic Tests Market in
APAC Region
11.4.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Abbott Laboratories
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Revenue by Business Segmentation
20.1.6 Revenue Comparison 2011 and 2012
20.1.7 Revenue by Geographical Segmentation
20.1.8 Key Information
20.1.9 SWOT Analysis
20.2 Becton, Dickinson
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Revenue Segmentation by Business
20.2.5 Revenue Comparison 2013 and 2012
20.2.6 Geographical Segmentation by Revenue
20.2.7 Business Strategy
20.2.8 Key Developments
20.2.9 SWOT Analysis
20.3 F. Hoffmann-La Roche
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation
Business Segmentation 20.3.4 by Revenue 2012 and 2013
20.3.5 Geographical Segmentation by Revenue
20.3.6 Business Strategy
20.3.7 Key Information
20.3.8 SWOT Analysis
20.4 Hologic
20.4.1 Key Facts
20.4.2 Business Description
20.4.3 Business Segmentation
20.4.4 Business Strategy
20.4.5 Revenue by Business Segmentation
20.4.6 Revenue Comparison 2012 and 2013
20.4.7 Revenue by Geographical Segmentation
20.4.8 Key Information
20.4.9 SWOT Analysis
20.5 Qiagen
20.5.1 Key Facts .
20.5.2 Business Overview
20.5.3 Product Segmentation by Revenue 2013
20.5.4 Product Segmentation by Revenue 2012 and 2013
20.5.5 Geographical Segmentation by Revenue 2013
20.5.6 Business Strategy
20.5.7 Recent Developments
20.5.8 SWOT Analysis
20.6 Quest Diagnostics
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Business Segmentation by Revenue 2013
Business Segmentation 20.6.4 by Revenue 2011-2013
20.6.5 Geographical Segmentation by Revenue 2013
20.6.6 Business Strategy
20.6.7 Recent Developments
20.6.8 SWOT Analysis
21. Other Reports in this Series